# Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata

> **NCT06088147** · NA · UNKNOWN · sponsor: **Al-Azhar University** · enrollment: 34 (estimated)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT06088147
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-06
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2023-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06088147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06088147, "Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06088147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*